{"id":925,"date":"2015-10-03T11:05:02","date_gmt":"2015-10-03T15:05:02","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=925"},"modified":"2015-10-03T11:14:16","modified_gmt":"2015-10-03T15:14:16","slug":"ipo-weekly-recap-edge-therapeutics-leads-the-way","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-edge-therapeutics-leads-the-way\/","title":{"rendered":"IPO Weekly Recap – Edge Therapeutics leads the way"},"content":{"rendered":"

This past week five IPOs debuted, five updated terms and two new deals were filed.<\/p>\n

\"ipo1003\"<\/a><\/p>\n

Of the five deals that debuted this past week, two opened below their offering prices and one opened flat. Each deal that opened for trade, needed their terms adjusted to fit the buy-side bids. Edge Therapeutics (Nasdaq: EDGE)<\/b><\/strong> was the best of the bunch as the deal opened 60-cents above the $11.00 pricing.\u00a0 \u2018EDGE\u2019 caught fire in the after-market as it traded to a first week high of $18.19 or 65% above the offering price before closing the week at $17.48.\u00a0 Performance Food Group (NYSE: PFGC)<\/b><\/strong> priced its deal $3.00 below the prevailing $22-$25 range and opened flat. However, \u2018PFGC\u2019 traded well, especially on day two, as the company closed its initial week at $21.18.\u00a0 A PE backed deal, Surgery Partners (Nasdaq: SGRY)<\/strong> priced $4.00 below its initial range and opened $1.45 below the offering price. However, the deal received support in the aftermarket and hit a first week high of $19.49.<\/p>\n

Looking ahead to this week, there are seven deals on the schedule and we are hearing early, positive street chatter about …<\/p>\n

Subscription Required<\/a><\/em><\/strong><\/p>\n

Calendar for Week of October 5th Deals<\/a><\/strong><\/p>\n

We may upgrade or downgrade an IPO and or secondary \u2013sometimes with not as much notice as we would like to give. If you have interest in IPOs do NOT delay your IOI\u2019s (hopefully they are already in)\u2026you can always cancel them. We will keep you posted if and as when\u2026we have anything pertinent to add. The current number of \u201cactive\u201d IPOs in the pipeline as of 10\/2\/15 is 121.\u00a0 Good luck trading!<\/p>\n","protected":false},"excerpt":{"rendered":"

This past week five IPOs debuted, five updated terms and two new deals were filed. Of the five deals that debuted this past week, two opened below their offering prices and one opened flat. Each deal that opened for trade, needed their terms adjusted to fit the buy-side bids. Edge Therapeutics (Nasdaq: EDGE) was the[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,22,141],"tags":[642,654,643,644,639],"class_list":["post-925","post","type-post","status-publish","format-standard","hentry","category-ipo","category-ipo-pricing","category-weekly-recap","tag-edge","tag-mirn","tag-nvcr","tag-sgry","tag-pfgc"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=925"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/925\/revisions"}],"predecessor-version":[{"id":931,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/925\/revisions\/931"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}